Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Hemorrhage | 136 | 2025 | 2655 | 14.350 |
Why?
|
Hematoma | 44 | 2024 | 766 | 6.730 |
Why?
|
Blood Coagulation Factors | 15 | 2024 | 371 | 3.080 |
Why?
|
Cerebral Angiography | 26 | 2021 | 1263 | 2.670 |
Why?
|
Vitamin K | 14 | 2024 | 314 | 2.480 |
Why?
|
Plasma | 11 | 2020 | 583 | 2.380 |
Why?
|
Warfarin | 15 | 2020 | 1493 | 2.080 |
Why?
|
Anticoagulants | 28 | 2024 | 4854 | 2.070 |
Why?
|
Intracranial Hemorrhages | 14 | 2023 | 810 | 1.900 |
Why?
|
Tomography, X-Ray Computed | 51 | 2023 | 20741 | 1.700 |
Why?
|
International Normalized Ratio | 14 | 2024 | 382 | 1.680 |
Why?
|
Status Epilepticus | 12 | 2023 | 459 | 1.630 |
Why?
|
Cerebral Amyloid Angiopathy | 14 | 2023 | 887 | 1.270 |
Why?
|
Stroke | 33 | 2024 | 9746 | 1.260 |
Why?
|
Antihypertensive Agents | 15 | 2024 | 2030 | 1.200 |
Why?
|
Hemostatics | 4 | 2021 | 247 | 1.060 |
Why?
|
Hypotension | 5 | 2024 | 888 | 1.040 |
Why?
|
Emergency Medical Services | 13 | 2024 | 1936 | 1.040 |
Why?
|
Blood Pressure | 15 | 2023 | 8531 | 1.000 |
Why?
|
Siderosis | 7 | 2023 | 100 | 0.960 |
Why?
|
Emergency Service, Hospital | 21 | 2024 | 7871 | 0.890 |
Why?
|
Patient Transfer | 4 | 2019 | 788 | 0.850 |
Why?
|
Critical Care | 6 | 2019 | 2714 | 0.850 |
Why?
|
Factor VIIa | 2 | 2020 | 103 | 0.820 |
Why?
|
Apolipoproteins E | 7 | 2019 | 1459 | 0.800 |
Why?
|
Clinical Protocols | 3 | 2018 | 1443 | 0.790 |
Why?
|
Aged, 80 and over | 79 | 2025 | 59548 | 0.750 |
Why?
|
Neurology | 3 | 2019 | 785 | 0.750 |
Why?
|
Midazolam | 4 | 2022 | 267 | 0.750 |
Why?
|
Cerebellar Diseases | 6 | 2025 | 227 | 0.750 |
Why?
|
Hemorrhage | 6 | 2023 | 3464 | 0.740 |
Why?
|
Coagulants | 1 | 2020 | 45 | 0.690 |
Why?
|
Aged | 120 | 2025 | 171319 | 0.690 |
Why?
|
Subarachnoid Hemorrhage | 6 | 2022 | 1023 | 0.690 |
Why?
|
Intensive Care Units | 9 | 2024 | 3797 | 0.680 |
Why?
|
Hematoma, Subdural, Intracranial | 3 | 2017 | 30 | 0.680 |
Why?
|
Nicardipine | 7 | 2021 | 59 | 0.680 |
Why?
|
Beluga Whale | 1 | 2019 | 2 | 0.660 |
Why?
|
Antifibrinolytic Agents | 5 | 2017 | 289 | 0.660 |
Why?
|
Factor IX | 2 | 2023 | 76 | 0.650 |
Why?
|
Humans | 223 | 2025 | 767040 | 0.610 |
Why?
|
Tissue Plasminogen Activator | 8 | 2024 | 1164 | 0.590 |
Why?
|
Thrombolytic Therapy | 7 | 2024 | 2054 | 0.560 |
Why?
|
Chaplaincy Service, Hospital | 1 | 2017 | 22 | 0.560 |
Why?
|
Male | 143 | 2025 | 364203 | 0.560 |
Why?
|
Prospective Studies | 50 | 2023 | 54886 | 0.550 |
Why?
|
Anticonvulsants | 7 | 2023 | 1921 | 0.550 |
Why?
|
Middle Aged | 109 | 2025 | 223233 | 0.540 |
Why?
|
Female | 145 | 2025 | 396660 | 0.530 |
Why?
|
Blood Loss, Surgical | 4 | 2024 | 642 | 0.520 |
Why?
|
Thromboembolism | 5 | 2019 | 1003 | 0.520 |
Why?
|
Retrospective Studies | 59 | 2025 | 81659 | 0.520 |
Why?
|
Hypoalbuminemia | 1 | 2017 | 90 | 0.520 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2018 | 429 | 0.520 |
Why?
|
Pastoral Care | 1 | 2017 | 72 | 0.510 |
Why?
|
Hospital Mortality | 12 | 2020 | 5345 | 0.510 |
Why?
|
Life Support Care | 1 | 2017 | 226 | 0.510 |
Why?
|
Pons | 2 | 2016 | 239 | 0.510 |
Why?
|
Glasgow Coma Scale | 7 | 2019 | 574 | 0.510 |
Why?
|
Intracranial Hemorrhage, Hypertensive | 4 | 2019 | 19 | 0.510 |
Why?
|
Antithrombins | 3 | 2017 | 294 | 0.510 |
Why?
|
Disease Progression | 18 | 2020 | 13646 | 0.510 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2016 | 171 | 0.490 |
Why?
|
Tidal Volume | 3 | 2015 | 519 | 0.490 |
Why?
|
Hypocalcemia | 1 | 2016 | 205 | 0.480 |
Why?
|
Third-Party Consent | 1 | 2015 | 66 | 0.470 |
Why?
|
Blood Coagulation | 2 | 2020 | 1163 | 0.470 |
Why?
|
Cohort Studies | 33 | 2021 | 41718 | 0.460 |
Why?
|
Brain Edema | 6 | 2020 | 601 | 0.450 |
Why?
|
Lorazepam | 1 | 2015 | 155 | 0.450 |
Why?
|
Delayed Diagnosis | 2 | 2020 | 454 | 0.450 |
Why?
|
Predictive Value of Tests | 21 | 2024 | 15424 | 0.450 |
Why?
|
Hypertension | 14 | 2025 | 8615 | 0.440 |
Why?
|
Consensus | 1 | 2023 | 3207 | 0.440 |
Why?
|
Serum Albumin | 1 | 2017 | 676 | 0.440 |
Why?
|
Factor X | 1 | 2013 | 64 | 0.440 |
Why?
|
Calcium | 2 | 2017 | 5792 | 0.440 |
Why?
|
Cerebral Arteries | 4 | 2017 | 490 | 0.430 |
Why?
|
Allied Health Personnel | 1 | 2015 | 156 | 0.430 |
Why?
|
Brain | 20 | 2022 | 27163 | 0.430 |
Why?
|
Patient Admission | 3 | 2019 | 1364 | 0.430 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 3 | 2011 | 101 | 0.430 |
Why?
|
Factor VII | 1 | 2013 | 139 | 0.420 |
Why?
|
Prothrombin | 1 | 2013 | 194 | 0.420 |
Why?
|
Ischemic Attack, Transient | 1 | 2018 | 874 | 0.400 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2013 | 135 | 0.390 |
Why?
|
Neurosurgical Procedures | 4 | 2024 | 2075 | 0.380 |
Why?
|
Logistic Models | 16 | 2021 | 13284 | 0.370 |
Why?
|
Emergency Treatment | 2 | 2020 | 495 | 0.370 |
Why?
|
Heparinoids | 1 | 2010 | 7 | 0.370 |
Why?
|
Informed Consent | 3 | 2015 | 1010 | 0.370 |
Why?
|
Emergency Medicine | 2 | 2019 | 1220 | 0.360 |
Why?
|
Heart Arrest | 2 | 2018 | 1516 | 0.360 |
Why?
|
Prognosis | 21 | 2023 | 29963 | 0.350 |
Why?
|
Brain Ischemia | 5 | 2023 | 3001 | 0.340 |
Why?
|
Ribonucleases | 3 | 2002 | 266 | 0.340 |
Why?
|
Apolipoprotein E2 | 4 | 2019 | 134 | 0.340 |
Why?
|
Fibrinolytic Agents | 7 | 2024 | 2079 | 0.340 |
Why?
|
Dizziness | 3 | 2024 | 269 | 0.330 |
Why?
|
Leukoaraiosis | 2 | 2021 | 114 | 0.330 |
Why?
|
Multivariate Analysis | 13 | 2020 | 12069 | 0.330 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2010 | 75 | 0.330 |
Why?
|
Cerebrum | 1 | 2010 | 132 | 0.330 |
Why?
|
Suicide, Attempted | 1 | 2018 | 1413 | 0.320 |
Why?
|
Treatment Outcome | 36 | 2024 | 65295 | 0.320 |
Why?
|
Acute Disease | 12 | 2024 | 7236 | 0.320 |
Why?
|
Statistics, Nonparametric | 5 | 2017 | 2850 | 0.310 |
Why?
|
Magnetic Resonance Imaging | 28 | 2025 | 36582 | 0.310 |
Why?
|
Positive-Pressure Respiration | 1 | 2013 | 713 | 0.310 |
Why?
|
Blood Coagulation Factor Inhibitors | 2 | 2021 | 14 | 0.310 |
Why?
|
American Heart Association | 4 | 2024 | 1049 | 0.310 |
Why?
|
Asymptomatic Diseases | 1 | 2011 | 588 | 0.300 |
Why?
|
Blood Coagulation Disorders | 1 | 2011 | 350 | 0.290 |
Why?
|
Hemosiderosis | 2 | 2019 | 66 | 0.290 |
Why?
|
Vasoconstrictor Agents | 3 | 2024 | 655 | 0.290 |
Why?
|
Length of Stay | 6 | 2020 | 6489 | 0.280 |
Why?
|
Cerebral Ventricles | 2 | 2020 | 550 | 0.280 |
Why?
|
Alexia, Pure | 1 | 2006 | 2 | 0.280 |
Why?
|
Mental Status Schedule | 1 | 2007 | 315 | 0.270 |
Why?
|
Encephalitis | 1 | 2010 | 441 | 0.270 |
Why?
|
Urinary Tract Infections | 3 | 2018 | 804 | 0.270 |
Why?
|
Intracranial Hypertension | 2 | 2023 | 191 | 0.270 |
Why?
|
Neurologic Examination | 2 | 2011 | 913 | 0.270 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2024 | 2811 | 0.270 |
Why?
|
Genetic Predisposition to Disease | 9 | 2019 | 18063 | 0.260 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2006 | 68 | 0.260 |
Why?
|
Factor Xa | 3 | 2022 | 165 | 0.260 |
Why?
|
Single-Blind Method | 4 | 2019 | 1587 | 0.250 |
Why?
|
Risk Factors | 33 | 2024 | 74886 | 0.250 |
Why?
|
Antidotes | 2 | 2018 | 138 | 0.240 |
Why?
|
Neurosurgery | 1 | 2012 | 682 | 0.240 |
Why?
|
Medical History Taking | 1 | 2009 | 779 | 0.240 |
Why?
|
Alleles | 3 | 2013 | 6893 | 0.240 |
Why?
|
Herpesvirus 1, Human | 3 | 2002 | 743 | 0.240 |
Why?
|
Public Opinion | 1 | 2008 | 484 | 0.230 |
Why?
|
Clinical Trials as Topic | 3 | 2021 | 8048 | 0.230 |
Why?
|
Capital Financing | 1 | 2024 | 58 | 0.230 |
Why?
|
Risk Assessment | 9 | 2024 | 24299 | 0.230 |
Why?
|
Cerebral Cortex | 7 | 2019 | 5754 | 0.210 |
Why?
|
Intensive Care Units, Pediatric | 3 | 2022 | 1023 | 0.210 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2017 | 8940 | 0.210 |
Why?
|
Epilepsy | 4 | 2020 | 3317 | 0.210 |
Why?
|
Vertigo | 1 | 2024 | 205 | 0.210 |
Why?
|
Research Design | 3 | 2019 | 6210 | 0.200 |
Why?
|
Headache | 3 | 2022 | 1261 | 0.190 |
Why?
|
Pneumonia | 3 | 2018 | 2159 | 0.190 |
Why?
|
Sinus Thrombosis, Intracranial | 2 | 2015 | 111 | 0.190 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5180 | 0.190 |
Why?
|
Time Factors | 14 | 2024 | 40154 | 0.180 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2019 | 951 | 0.180 |
Why?
|
Endothelin-1 | 1 | 2022 | 296 | 0.180 |
Why?
|
Pentobarbital | 2 | 2022 | 153 | 0.180 |
Why?
|
Recombinant Proteins | 5 | 2022 | 6507 | 0.180 |
Why?
|
Acute Kidney Injury | 2 | 2012 | 1946 | 0.180 |
Why?
|
Severity of Illness Index | 10 | 2017 | 15925 | 0.170 |
Why?
|
Ambulatory Care | 1 | 2011 | 2780 | 0.170 |
Why?
|
Quality Indicators, Health Care | 3 | 2023 | 1804 | 0.170 |
Why?
|
Crowding | 1 | 2020 | 142 | 0.160 |
Why?
|
Patient Education as Topic | 2 | 2008 | 2337 | 0.160 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3431 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2023 | 10393 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2023 | 473 | 0.160 |
Why?
|
Blood Transfusion | 1 | 2005 | 1308 | 0.160 |
Why?
|
Photoperiod | 1 | 2019 | 141 | 0.150 |
Why?
|
Hemostasis | 1 | 2021 | 467 | 0.150 |
Why?
|
Odds Ratio | 6 | 2019 | 9660 | 0.150 |
Why?
|
Regional Health Planning | 1 | 2018 | 95 | 0.150 |
Why?
|
Nervous System Diseases | 1 | 2009 | 1660 | 0.150 |
Why?
|
Sodium Bicarbonate | 1 | 2018 | 60 | 0.150 |
Why?
|
Benzodiazepines | 2 | 2023 | 1137 | 0.150 |
Why?
|
Administration, Oral | 3 | 2022 | 4026 | 0.150 |
Why?
|
Erythrocyte Transfusion | 2 | 2013 | 575 | 0.140 |
Why?
|
Genotype | 9 | 2016 | 13035 | 0.140 |
Why?
|
Subarachnoid Space | 1 | 2017 | 78 | 0.140 |
Why?
|
Follow-Up Studies | 12 | 2021 | 39317 | 0.140 |
Why?
|
Brain Infarction | 2 | 2023 | 285 | 0.130 |
Why?
|
Blood Component Transfusion | 1 | 2017 | 141 | 0.130 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14672 | 0.130 |
Why?
|
Bradycardia | 1 | 2018 | 305 | 0.130 |
Why?
|
Boston | 4 | 2020 | 9360 | 0.130 |
Why?
|
Infusions, Intravenous | 5 | 2024 | 2227 | 0.130 |
Why?
|
Pharmacists | 1 | 2018 | 261 | 0.130 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2016 | 113 | 0.130 |
Why?
|
Observer Variation | 2 | 2019 | 2616 | 0.130 |
Why?
|
Hospitals | 4 | 2022 | 3883 | 0.130 |
Why?
|
Case-Control Studies | 11 | 2023 | 22254 | 0.120 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2016 | 138 | 0.120 |
Why?
|
Urine | 1 | 2017 | 362 | 0.120 |
Why?
|
Genetic Variation | 4 | 2015 | 6611 | 0.120 |
Why?
|
Critical Pathways | 1 | 2019 | 476 | 0.120 |
Why?
|
Adult | 32 | 2024 | 223317 | 0.120 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2017 | 2764 | 0.120 |
Why?
|
Electric Countershock | 1 | 2018 | 534 | 0.120 |
Why?
|
Brain Stem Hemorrhage, Traumatic | 1 | 2014 | 13 | 0.120 |
Why?
|
Random Allocation | 1 | 2019 | 2394 | 0.120 |
Why?
|
Lymphopenia | 1 | 2017 | 300 | 0.120 |
Why?
|
Hemostasis, Surgical | 1 | 2015 | 128 | 0.120 |
Why?
|
Blood | 1 | 2017 | 596 | 0.110 |
Why?
|
Peroxidase | 1 | 2017 | 610 | 0.110 |
Why?
|
Sputum | 1 | 2017 | 514 | 0.110 |
Why?
|
Gossypium | 1 | 2014 | 36 | 0.110 |
Why?
|
Pest Control, Biological | 1 | 2014 | 21 | 0.110 |
Why?
|
Pregnanolone | 1 | 2014 | 67 | 0.110 |
Why?
|
Hospitals, Urban | 1 | 2016 | 495 | 0.110 |
Why?
|
Plants, Genetically Modified | 1 | 2014 | 113 | 0.110 |
Why?
|
Drainage | 1 | 2020 | 1183 | 0.110 |
Why?
|
Craniocerebral Trauma | 1 | 2018 | 493 | 0.110 |
Why?
|
Chiroptera | 1 | 2014 | 62 | 0.110 |
Why?
|
Microvessels | 1 | 2017 | 585 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 412 | 0.110 |
Why?
|
Respiration, Artificial | 2 | 2015 | 2726 | 0.110 |
Why?
|
Sepsis | 2 | 2018 | 2605 | 0.110 |
Why?
|
Cognition Disorders | 1 | 2007 | 3968 | 0.110 |
Why?
|
Practice Guidelines as Topic | 5 | 2024 | 7435 | 0.110 |
Why?
|
Registries | 3 | 2019 | 8351 | 0.110 |
Why?
|
Genome-Wide Association Study | 5 | 2017 | 12790 | 0.100 |
Why?
|
Biomedical Research | 1 | 2008 | 3464 | 0.100 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 2013 | 59 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1396 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2019 | 20169 | 0.100 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2016 | 418 | 0.100 |
Why?
|
Apolipoprotein E4 | 2 | 2019 | 709 | 0.100 |
Why?
|
Electroencephalography | 2 | 2022 | 6282 | 0.100 |
Why?
|
Water-Electrolyte Balance | 1 | 2013 | 326 | 0.100 |
Why?
|
Diagnosis, Differential | 6 | 2018 | 12986 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2016 | 1606 | 0.100 |
Why?
|
Insecticides | 1 | 2014 | 203 | 0.100 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2014 | 640 | 0.100 |
Why?
|
DNA, Viral | 1 | 1998 | 2201 | 0.100 |
Why?
|
Electrocardiography | 2 | 2018 | 6409 | 0.090 |
Why?
|
DNA Replication | 1 | 1998 | 1426 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3618 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1156 | 0.090 |
Why?
|
Atrophy | 2 | 2020 | 1631 | 0.090 |
Why?
|
Deferoxamine | 1 | 2011 | 155 | 0.090 |
Why?
|
Massachusetts | 3 | 2020 | 8890 | 0.090 |
Why?
|
Survival Analysis | 3 | 2017 | 10092 | 0.090 |
Why?
|
Hospital Charges | 1 | 2012 | 345 | 0.090 |
Why?
|
Monitoring, Physiologic | 2 | 2022 | 1794 | 0.090 |
Why?
|
Oxidative Phosphorylation | 1 | 2013 | 501 | 0.090 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 418 | 0.090 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2015 | 372 | 0.090 |
Why?
|
Tomography, Spiral Computed | 1 | 2012 | 273 | 0.090 |
Why?
|
Blood Pressure Determination | 2 | 2018 | 646 | 0.090 |
Why?
|
Pyridones | 3 | 2021 | 819 | 0.090 |
Why?
|
Muscle Rigidity | 1 | 2010 | 41 | 0.090 |
Why?
|
Recurrence | 5 | 2021 | 8504 | 0.080 |
Why?
|
Thrombectomy | 1 | 2014 | 676 | 0.080 |
Why?
|
Brain Diseases | 1 | 2019 | 1551 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2013 | 377 | 0.080 |
Why?
|
Pulmonary Edema | 1 | 2012 | 408 | 0.080 |
Why?
|
Pilot Projects | 6 | 2022 | 8732 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2783 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1883 | 0.080 |
Why?
|
Genes | 1 | 2013 | 1824 | 0.080 |
Why?
|
Blood Pressure Monitors | 1 | 2008 | 33 | 0.080 |
Why?
|
Sex Factors | 4 | 2018 | 10622 | 0.080 |
Why?
|
Seizures | 3 | 2023 | 2996 | 0.080 |
Why?
|
Child | 16 | 2023 | 80771 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2015 | 6215 | 0.080 |
Why?
|
Ambulatory Care Facilities | 1 | 2014 | 939 | 0.080 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2010 | 184 | 0.080 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12536 | 0.080 |
Why?
|
Rett Syndrome | 1 | 2010 | 164 | 0.080 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2016 | 996 | 0.080 |
Why?
|
Adolescent | 14 | 2022 | 89046 | 0.070 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2013 | 621 | 0.070 |
Why?
|
Hematoma, Subdural | 1 | 2009 | 128 | 0.070 |
Why?
|
Intermittent Pneumatic Compression Devices | 2 | 2022 | 28 | 0.070 |
Why?
|
Drug Combinations | 1 | 2013 | 2086 | 0.070 |
Why?
|
Developmental Disabilities | 2 | 2020 | 1518 | 0.070 |
Why?
|
Mathematics | 1 | 2008 | 696 | 0.070 |
Why?
|
Emergencies | 1 | 2013 | 1223 | 0.070 |
Why?
|
Fibrinogen | 1 | 2010 | 892 | 0.070 |
Why?
|
Early Diagnosis | 2 | 2014 | 1188 | 0.070 |
Why?
|
Radial Artery | 1 | 2008 | 187 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2017 | 2647 | 0.070 |
Why?
|
Disability Evaluation | 2 | 2017 | 1829 | 0.070 |
Why?
|
Radiography | 2 | 2014 | 6975 | 0.060 |
Why?
|
Mitochondrial Diseases | 1 | 2010 | 344 | 0.060 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1193 | 0.060 |
Why?
|
Recovery of Function | 2 | 2024 | 2978 | 0.060 |
Why?
|
Disasters | 1 | 2012 | 521 | 0.060 |
Why?
|
United States | 11 | 2024 | 72971 | 0.060 |
Why?
|
Preoperative Care | 1 | 2015 | 2252 | 0.060 |
Why?
|
Microcephaly | 1 | 2010 | 426 | 0.060 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 978 | 0.060 |
Why?
|
Data Interpretation, Statistical | 2 | 2014 | 2698 | 0.060 |
Why?
|
Cerebellum | 2 | 2025 | 1521 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18401 | 0.060 |
Why?
|
Lung Diseases | 1 | 2015 | 1942 | 0.060 |
Why?
|
Vision Disorders | 1 | 2012 | 1090 | 0.060 |
Why?
|
Pyrazoles | 3 | 2021 | 2028 | 0.060 |
Why?
|
Contrast Media | 2 | 2009 | 5329 | 0.060 |
Why?
|
Morphine | 2 | 2014 | 658 | 0.060 |
Why?
|
Fever | 1 | 2012 | 1605 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2010 | 1472 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2753 | 0.060 |
Why?
|
Sleep | 1 | 2020 | 4816 | 0.060 |
Why?
|
Information Theory | 1 | 2024 | 49 | 0.060 |
Why?
|
Demography | 1 | 2008 | 1641 | 0.050 |
Why?
|
Troponin T | 2 | 2023 | 786 | 0.050 |
Why?
|
Migraine Disorders | 1 | 2016 | 1712 | 0.050 |
Why?
|
Age of Onset | 1 | 2010 | 3344 | 0.050 |
Why?
|
Creatinine | 1 | 2009 | 1916 | 0.050 |
Why?
|
Angiography | 1 | 2009 | 1597 | 0.050 |
Why?
|
Entropy | 1 | 2024 | 210 | 0.050 |
Why?
|
Algorithms | 1 | 2024 | 14098 | 0.050 |
Why?
|
Drug Interactions | 1 | 2008 | 1419 | 0.050 |
Why?
|
Hyperglycemia | 1 | 2011 | 1388 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2920 | 0.050 |
Why?
|
Prevalence | 3 | 2020 | 15851 | 0.050 |
Why?
|
Patient Discharge | 2 | 2012 | 3467 | 0.050 |
Why?
|
Quality Improvement | 2 | 2014 | 3854 | 0.050 |
Why?
|
Diazepam | 1 | 2023 | 215 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2744 | 0.050 |
Why?
|
Vero Cells | 2 | 2002 | 486 | 0.050 |
Why?
|
Aspirin | 1 | 2013 | 3135 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2018 | 4422 | 0.050 |
Why?
|
Intracranial Pressure | 1 | 2023 | 323 | 0.050 |
Why?
|
Health Personnel | 1 | 2015 | 3387 | 0.050 |
Why?
|
Comorbidity | 4 | 2020 | 10582 | 0.050 |
Why?
|
Survival Rate | 5 | 2016 | 12823 | 0.050 |
Why?
|
Sex Distribution | 1 | 2006 | 2276 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2010 | 1217 | 0.050 |
Why?
|
Receptors, Peptide | 1 | 2022 | 280 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2008 | 2741 | 0.040 |
Why?
|
Software | 2 | 2017 | 4472 | 0.040 |
Why?
|
Child, Preschool | 7 | 2020 | 42606 | 0.040 |
Why?
|
General Surgery | 1 | 2012 | 1720 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 2007 | 1478 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2009 | 1161 | 0.040 |
Why?
|
Age Distribution | 1 | 2006 | 2870 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2011 | 2131 | 0.040 |
Why?
|
Optic Nerve | 1 | 2023 | 568 | 0.040 |
Why?
|
Quality of Life | 1 | 2022 | 13485 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2024 | 12451 | 0.040 |
Why?
|
Capsid | 1 | 2002 | 435 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3249 | 0.040 |
Why?
|
Pediatrics | 1 | 2014 | 3621 | 0.040 |
Why?
|
Triage | 1 | 2006 | 995 | 0.040 |
Why?
|
Apolipoprotein E3 | 1 | 2019 | 105 | 0.040 |
Why?
|
Infant | 6 | 2020 | 36485 | 0.040 |
Why?
|
Haptoglobins | 1 | 2020 | 165 | 0.040 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 1998 | 142 | 0.040 |
Why?
|
Magnetic Resonance Angiography | 2 | 2017 | 1429 | 0.040 |
Why?
|
Recombinases | 1 | 1998 | 70 | 0.040 |
Why?
|
Endpoint Determination | 1 | 2021 | 592 | 0.040 |
Why?
|
Transposases | 1 | 1998 | 106 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7210 | 0.040 |
Why?
|
Defective Viruses | 1 | 1998 | 89 | 0.040 |
Why?
|
Young Adult | 7 | 2020 | 59980 | 0.040 |
Why?
|
Phenprocoumon | 1 | 2017 | 19 | 0.040 |
Why?
|
Hemophilia A | 1 | 2021 | 359 | 0.040 |
Why?
|
Enzyme Stability | 1 | 1998 | 218 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2022 | 752 | 0.040 |
Why?
|
Genetic Complementation Test | 1 | 1998 | 556 | 0.040 |
Why?
|
Mortality | 2 | 2020 | 2909 | 0.040 |
Why?
|
Base Sequence | 2 | 1998 | 12414 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1998 | 705 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2022 | 1864 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2007 | 6023 | 0.030 |
Why?
|
Blood Glucose | 1 | 2011 | 6421 | 0.030 |
Why?
|
Incidence | 3 | 2017 | 21526 | 0.030 |
Why?
|
Inflammation | 1 | 2017 | 10869 | 0.030 |
Why?
|
Genes, Viral | 1 | 1998 | 654 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2019 | 490 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 1998 | 351 | 0.030 |
Why?
|
Neutrophils | 2 | 2022 | 3779 | 0.030 |
Why?
|
Inpatients | 1 | 2008 | 2563 | 0.030 |
Why?
|
Animals | 6 | 2019 | 168965 | 0.030 |
Why?
|
Disease Management | 2 | 2019 | 2531 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9464 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2003 | 1069 | 0.030 |
Why?
|
Edema | 1 | 2020 | 764 | 0.030 |
Why?
|
Thailand | 1 | 2016 | 288 | 0.030 |
Why?
|
Cerebral Palsy | 1 | 2020 | 480 | 0.030 |
Why?
|
New England | 1 | 2018 | 1058 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 418 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2003 | 1278 | 0.030 |
Why?
|
Iodine | 1 | 2017 | 285 | 0.030 |
Why?
|
Leukocytosis | 1 | 2016 | 248 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1998 | 1160 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 817 | 0.030 |
Why?
|
Time and Motion Studies | 1 | 2014 | 143 | 0.030 |
Why?
|
Infusions, Intra-Arterial | 1 | 2014 | 220 | 0.030 |
Why?
|
Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2016 | 16036 | 0.030 |
Why?
|
Risk | 2 | 2018 | 9606 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1733 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1126 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 4052 | 0.030 |
Why?
|
DNA Primers | 1 | 1998 | 2827 | 0.030 |
Why?
|
Body Mass Index | 1 | 2011 | 13048 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 1998 | 1524 | 0.030 |
Why?
|
Punctures | 1 | 2014 | 371 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2022 | 4881 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 8068 | 0.030 |
Why?
|
Neuromuscular Blockade | 1 | 2014 | 148 | 0.030 |
Why?
|
Analgesics, Opioid | 2 | 2014 | 3837 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2018 | 903 | 0.030 |
Why?
|
Spinal Puncture | 1 | 2014 | 284 | 0.030 |
Why?
|
Head | 1 | 2018 | 926 | 0.020 |
Why?
|
Milk | 1 | 2015 | 437 | 0.020 |
Why?
|
Hospitalization | 1 | 2011 | 10815 | 0.020 |
Why?
|
Mass Screening | 1 | 2007 | 5456 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2017 | 14766 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2020 | 1856 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 13085 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2018 | 2428 | 0.020 |
Why?
|
Fentanyl | 1 | 2014 | 451 | 0.020 |
Why?
|
Gene Deletion | 1 | 1998 | 2668 | 0.020 |
Why?
|
Basal Ganglia | 1 | 2013 | 549 | 0.020 |
Why?
|
Ultrasonography | 1 | 2023 | 6000 | 0.020 |
Why?
|
Altruism | 1 | 2012 | 211 | 0.020 |
Why?
|
Electron Transport Complex III | 1 | 2010 | 31 | 0.020 |
Why?
|
Thiazoles | 1 | 2017 | 1530 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2016 | 1816 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2105 | 0.020 |
Why?
|
Hematocrit | 1 | 2011 | 622 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 859 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2020 | 2672 | 0.020 |
Why?
|
Ecosystem | 1 | 2014 | 489 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5875 | 0.020 |
Why?
|
Hemodynamics | 1 | 2020 | 4186 | 0.020 |
Why?
|
Subdural Space | 1 | 2009 | 38 | 0.020 |
Why?
|
Organ Size | 1 | 2014 | 2264 | 0.020 |
Why?
|
Embolism | 1 | 2012 | 401 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2010 | 212 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2014 | 935 | 0.020 |
Why?
|
United States Government Agencies | 1 | 2008 | 26 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1178 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2487 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2022 | 5537 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2021 | 2513 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3700 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 26325 | 0.020 |
Why?
|
Propofol | 1 | 2014 | 608 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 935 | 0.020 |
Why?
|
Phenotype | 2 | 2013 | 16718 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2591 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1512 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 2009 | 560 | 0.020 |
Why?
|
Thalamus | 1 | 2013 | 1040 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 812 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6513 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6777 | 0.020 |
Why?
|
Telemedicine | 1 | 2024 | 3110 | 0.020 |
Why?
|
Troponin I | 1 | 2011 | 659 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2232 | 0.020 |
Why?
|
Monocytes | 1 | 2016 | 2598 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2024 | 5363 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13411 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6310 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2505 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 3683 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2014 | 2131 | 0.020 |
Why?
|
Pyridines | 1 | 2017 | 2890 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 17608 | 0.020 |
Why?
|
Benchmarking | 1 | 2012 | 1056 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2011 | 2350 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2020 | 4306 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 1233 | 0.010 |
Why?
|
Point Mutation | 1 | 2010 | 1591 | 0.010 |
Why?
|
Pandemics | 1 | 2024 | 8736 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3618 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3804 | 0.010 |
Why?
|
Patient Care Team | 1 | 2014 | 2516 | 0.010 |
Why?
|
Codon, Initiator | 1 | 2002 | 50 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 2002 | 297 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6331 | 0.010 |
Why?
|
Anemia | 1 | 2011 | 1514 | 0.010 |
Why?
|
Medicare | 1 | 2019 | 6813 | 0.010 |
Why?
|
Retina | 1 | 2012 | 2659 | 0.010 |
Why?
|
Peritonitis | 1 | 2003 | 368 | 0.010 |
Why?
|
Educational Status | 1 | 2008 | 2511 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2008 | 1405 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 7848 | 0.010 |
Why?
|
Income | 1 | 2008 | 1877 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6260 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2011 | 3108 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2008 | 2429 | 0.010 |
Why?
|
Withholding Treatment | 1 | 2003 | 619 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10748 | 0.010 |
Why?
|
Health Care Costs | 1 | 2011 | 3239 | 0.010 |
Why?
|
Mutation | 2 | 2002 | 30211 | 0.010 |
Why?
|
Insulin | 1 | 2011 | 6602 | 0.010 |
Why?
|
Physical Examination | 1 | 2003 | 1265 | 0.010 |
Why?
|
Patient Selection | 1 | 2008 | 4256 | 0.010 |
Why?
|
Insurance, Health | 1 | 2008 | 2519 | 0.010 |
Why?
|
Amyloid beta-Peptides | 1 | 2009 | 3886 | 0.010 |
Why?
|
Blotting, Western | 1 | 2002 | 5022 | 0.010 |
Why?
|
Decision Making | 1 | 2007 | 3951 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2007 | 3928 | 0.010 |
Why?
|
Pain Measurement | 1 | 2003 | 3584 | 0.010 |
Why?
|
Clinical Competence | 1 | 2007 | 4859 | 0.010 |
Why?
|
Asthma | 1 | 2008 | 6268 | 0.000 |
Why?
|
Cell Line | 1 | 2002 | 15567 | 0.000 |
Why?
|
Internship and Residency | 1 | 2007 | 5947 | 0.000 |
Why?
|